Sientra jumps on FDA's nod for breast tissue expander

Project Sage Oldco

09/06/2023 11:15

** Shares of medical aesthetics firm Sientra Inc  SIEN.O 
jump 76% to $3.1 before the bell
    ** Stock top pct. gainer across U.S. stock exchanges
premarket
    ** Co late Thursday reported that the U.S. FDA granted
marketing clearance for its breast tissue expander AlloX2 Pro
    ** A tissue expander is an empty implant used in
reconstruction surgeries
    ** SIEN adds that with the approval AlloX2 Pro becomes the
first MRI-compatible tissue expander available in the U.S.
market
    ** The nod for AlloX2 Pro makes it SIEN's third product
approved by the FDA in the past 12 months
    ** FDA last month granted marketing clearance for co's 
Portfinder, an electronic handheld device that allows clinicians
to locate the right administration spot for tissue expansion
    ** Up to Thursday's close, stock fell 13.75% YTD

 (Reporting by Pratik Jain in Bengaluru)
 ((Pratik.Jain@thomsonreuters.com;))